In the same year, Kim et al. (41) proposed a method using diffusion and perfusion-weighted MRI radiomics models to predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse low-grade gliomas. Here, IDH1 is linked to neoplasm.